Hydrogen Sulfide (H2S): The new member of gasotransmitter family

Biomedical Reviews

Volumn 18, Issue , 2007, Pages 75-83

  Beltowski, Jerzy ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Arterial hypertension; Atherosclerosis; Hydrogen sulfide; Inflammation; Neurotransmission; Vascular tone

Indexed keywords

EID: 78249242111     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v18.71     Document Type: Article

References (85)

1. Reiffenstein RJ, Hulbert WC, Roth SH. Toxicology of hydrogen sulfide. Annu Rev Pharmacol Toxico, 1992; 32: 109-134.
2. Abe K, Kimura H. The possible role of hydrogen sulfide as an endogenous neuromodulator. J Neurosci 1996; 16: 1066-1071.
3. Szabó C. Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 2007; 6: 917-935.
4. 2S) - the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24.
5. Pearson RJ, Wilson T, Wang R. Endogenous hydrogen sulfide and the cardiovascular system-what's the smell all about? Clin Invest Med 2006; 29: 146-150.
6. Fiorucci S, Distrutti E, Cirino G, Wallace JL. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 2006; 131: 259-271.
7. Doeller JE, Isbell TS, Benavides G, Koenitzer J, Patel H, Patel RP, et al. Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues. Anal Biochem 2005; 341: 40-51.
8. Stipanuk MH, De la Rosa J, Hirschberger LL. Catabolism of cysteine by rat renal cortical tubules. J Nutr 1990; 120: 450-458.
9. Puranik M, Weeks CL, Lahaye D, Kabil O, Taoka S, Nielsen SB, et al. Dynamics of carbon monoxide binding to cystathionine β-synthase. J Biol Chem 2006; 281: 13433-13438.
10. 2S in rat tissues. Can J Physiol Pharmacol 2003; 81: 848-853.
11. 2S as a novel endogenous gaseous KATP channel opener. EMBO J 2001; 20: 6008-6016.
12. Attene-Ramos MS, Wagner ED, Gaskins HR, Plewa MJ. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res 2007; 5: 455-459.
13. Ramasamy S, Singh S, Taniere P, Langman MJ, Eggo MC. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 2006; 291: G288- G296.
14. Goubern M, Andriamihaja M, Nübel T, Blachier F, Bouillaud F. Sulfide, the first inorganic substrate for human cells. FASEB J 2007; 21: 1699-1706.
15. Mitsuhashi H, Yamashita S, Ikeuchi H, Kuroiwa T, Kaneko Y, Hiromura K, et al. Oxidative stress-dependent conversion of hydrogen sulfide to sulfite by activated neutrophils. Shock 2005; 24: 529-534.
16. Geng B, Chang L, Pan C, Qi Y, Zhao J, Pang Y, et al. Endogenous hydrogen sulfide regulation of myocardial injury induced by isoproterenol. Biochem Biophys Res Commun 2004; 318: 756-763.
17. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, et al. The novel neuromodulator hydrogen sulfide: an endogenous peroxynitrite 'scavenger'? J Neurochem 2004; 90: 765-768.
18. Whiteman M, Cheung NS, Zhu YZ, Chu SH, Siau JL, Wong BS, et al. Hydrogen sulphide: a novel inhibitor of hypochlorous acid-mediated oxidative damage in the brain?. Biochem Biophys Res Commun 2005; 326: 794-798.
19. Collin M, Thiemermann C. Hydrogen sulfide and sulfite: novel mediators in the pathophysiology of shock and inflammation. Shock 2005; 24: 595-596.
20. Kimura H. Hydrogen sulfide induces cyclic AMP and modulates the NMDA receptor. Biochem Biophys Res Commun 2000; 267: 129-133.
21. Nagai Y, Tsugane M, Oka J, Kimura H. Hydrogen sulfide induces calcium waves in astrocytes FASEB J 2004; 18: 557-559.
22. 2+ channels. Antioxid Redox Signal 2008; 10: 31-42.
23. 2S) contractile activity in rat detrusor muscle. Eur J Pharmacol 2005; 509: 171-177.
24. Belardinelli MC, Chabli A, Chadefaux-Vekemans B, Kamoun P. Urinary sulfur compounds in Down syndrome. Clin Chem 2001; 47: 1500-1501.
25. Kamoun P. Mental retardation in Down syndrome: a hydrogen sulfide hypothesis. Med Hypotheses 2001; 57: 389-392.
26. Qu K, Chen CP, Halliwell B, Moore PK, Wong PT. Hydrogen sulfide is a mediator of cerebral ischemic damage. Stroke 2006; 37: 889-893.
27. Cheung NS, Peng ZF, Chen MJ, Moore PK, Whiteman M. Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons. Neuropharmacology 2007; 53: 505-514.
28. Kimura Y, Dargusch R, Schubert D, Kimura H. Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 2006; 8: 661-670.
29. Kimura Y, Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004; 18: 1165-1167.
30. Eto K, Asada T, Arima K, Makifuchi T, Kimura H. Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 2002; 293: 1485-1488.
31. 2S induces a suspended animation-like state in mice. Science 2005; 3085: 518.
32. Blackstone E, Roth MB. Suspended animation-like state protects mice from lethal hypoxia. Shock 2007; 27: 370-372.
33. Hu X, Li T, Bi S, Jin Z, Zhou G, Bai C, et al. Possible role of hydrogen sulfide on the preservation of donor rat hearts. Transplant Proc 2007; 39: 3024-3029.
34. Miller DL, Roth MB. Hydrogen sulfide increases thermotolerance and lifespan in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2007; 104: 20618-20622.
35. 2S induced hypometabolism in mice is missing in sedated sheep. Respir Physiol Neurobiol 2008; 160: 109-115.
36. Cheng Y, Ndisang JF, Tang G, Cao K, Wang R. Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats. Am J Physiol Heart Circ Physiol 2004; 287: H2316-H2323.
37. Tang G, Wu L, Liang W, Wang R. Direct stimulation of KATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol 2005; 68: 1757-1764.
38. 2-dependent manner. Am J Physiol Heart Circ Physiol 2007; 292: H1953-H1960.
39. Ali MY, Ping CY, Mok YY, Ling L, Whiteman M, Bhatia M, et al. Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide? Br J Pharmacol 2006; 149: 625-634.
40. Webb GD, Lim LH, Oh VM, Yeo SB, Cheong YP, Ali MY, et al. Contractile and vasorelaxant effects of hydrogen sulfide and its biosynthesis in the human internal mammary artery. J Pharmacol Exp Ther 2008; 324: 876-882.
41. Whiteman M, Li L, Kostetski I, Chu SH, Siau JL, Bhatia M, et al. Evidence for the formation of a novel nitrosothiol from the gaseous mediators nitric oxide and hydrogen sulphide. Biochem Biophys Res Commun 2006; 343: 303-310.
42. Kubo S, Kurokawa Y, Doe I, Masuko T, Sekiguchi F, Kawabata A. Hydrogen sulfide inhibits activity of three isoforms of recombinant nitric oxide synthase. Toxicology 2007; 241: 92-97.
43. Xiao L, Wu YM, Zhang H, Liu YX, He RR. Hydrogen sulfide facilitates carotid sinus baroreflex in anesthetized rats. Acta Pharmacol Sin 2006; 27: 294-298.
44. 2S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313: 362-368.
45. Cai WJ, Wang MJ, Moore PK, Jin HM, Yao T, Zhu YC. The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc Res 2007; 76: 29-40.
46. Laggner H, Hermann M, Esterbauer H, Muellner MK, Exner M, Gmeiner BM, et al. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells. J Hypertens 2007; 25: 2100-2104.
47. Yan H, Du J, Tang C. The possible role of hydrogen sulfide on the pathogenesis of spontaneous hypertension in rats. Biochem Biophys Res Commun 2004; 313: 22-27.
48. Zhong G, Chen F, Cheng Y, Tang C, Du J. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase. J Hypertens 2003; 21: 1879-1885.
49. Chen L, Ingrid S, Ding YG, Liu Y, Qi JG, Tang CS, et al. Imbalance of endogenous homocysteine and hydrogen sulfide metabolic pathway in essential hypertensive children. Chin Med J 2007; 120: 389-393.
50. Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80.
51. Yang G, Sun X, Wang R. Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3. FASEB J 2004; 18: 1782-1784.
52. Laggner H, Muellner MK, Schreier S, Sturm B, Hermann M, Exner M et al. Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOCl. Free Radic Res 2007; 41: 741-747.
53. Zagli G, Patacchini R, Trevisani M, Abbate R, Cinotti S, Gensini GF, et al. Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol 2007; 559: 65-68.
54. Yan SK, Chang T, Wang H, Wu L, Wang R, Meng QH. Effects of hydrogen sulfide on homocysteine-induced oxidative stress in vascular smooth muscle cells. Biochem Biophys Res Commun 2006; 351: 485-491.
55. Meng QH, Yang G, Yang W, Jiang B, Wu L, Wang R. Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries. Am J Pathol 2007; 170: 1406-1414.
56. Wu SY, Pan CS, Geng B, Zhao J, Yu F, Pang YZ, et al. Hydrogen sulfide ameliorates vascular calcification induced by vitamin D3 plus nicotine in rats. Acta Pharmacol Sin 2006; 27: 299-306.
57. O'Rourke B. Myocardial KATP channels in preconditioning. Circ Res 2000; 87: 845-855.
58. 2S) protects against regional myocardial ischemia-reperfusion injury-evidence for a role of KATP channels. Basic Res Cardiol 2006; 101: 53-60.
59. Zhu YZ, Wang ZJ, Ho P, Loke YY, Zhu YC, Huang XW, et al. Hydrogen sulfide and its cardioprotective effects in myocardial ischemia in experimental rats. J Appl Physiol 2007; 102: 261-268.
60. Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY, Zhou S, et al. Role of hydrogen sulfide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. J Pharmacol Exp Ther 2006; 316: 670-678.
61. Chunyu Z, Junbao D, Dingfang B, Hui Y, Xiuying T, Chaoshu T. The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats. Biochem Biophys Res Commun 2003; 302: 810-816.
62. Xiaohui L, Junbao D, Lin S, Jian L, Xiuying T, Jianguang Q, et al. Down-regulation of endogenous hydrogen sulfide pathway in pulmonary hypertension and pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Circ J 2005; 69: 1418-1424.
63. Hongfang J, Bailin C, Bin Z, Chunyu Z, Xinmin L, Weijin Z, et al. Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling. Life Sci 2006; 78: 1299-1309.
64. Li XH, Du JB, Bu DF, Tang XY, Tang CS. Sodium hydrosulfide alleviated pulmonary vascular structural remodeling induced by high pulmonary blood flow in rats. Acta Pharmacol Sin 2006; 27: 971-980.
65. Li L, Bhatia M, Moore PK. Hydrogen sulphide--a novel mediator of inflammation? Curr Opin Pharmacol 2006; 6: 125-129.
66. 2S) content during septic shock and endotoxic shock in rats. J Infect 2003; 47: 155-160.
67. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide- induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198.
68. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1193-L1201.
69. Bhatia M, Wong FL, Fu D, Lau HY, Moochhala SM, Moore PK. Role of hydrogen sulfide in acute pancreatitis and associated lung injury. FASEB J 2005; 19: 623-625.
70. Trevisani M, Patacchini R, Nicoletti P, Gatti R, Gazzieri D, Lissi N, et al. Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways. Br J Pharmacol 2005; 145: 1123-1131.
71. Bhatia M, Zhi L, Zhang H, Ng SW, Moore PK. Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2006; 291: L896-L904.
72. Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, et al. Endogenous hydrogen sulfide in patients with COPD. Chest 2005; 128: 3205-3211.
73. Morselli-Labate AM, Fantini L, Pezzilli R. Hydrogen sulfide, nitric oxide and a molecular mass 66 u substance in the exhaled breath of chronic pancreatitis patients. Pancreatology 2007; 7: 497-504.
74. 2S in rat insulin-secreting cells and the underlying mechanisms. J Physiol 2005; 569: 519-531.
75. Kaneko Y, Kimura Y, Kimura H, Niki I. L-cysteine inhibits insulin release from the pancreatic β-cell: possible involvement of metabolic production of hydrogen sulfide, a novel gasotransmitter. Diabetes 2006; 55: 1391-1397.
76. Yusuf M, Kwong Huat BT, Hsu A, Whiteman M, Bhatia M, Moore PK. Streptozotocin-induced diabetes in the rat is associated with enhanced tissue hydrogen sulfide biosynthesis. Biochem Biophys Res Commun 2005; 333: 1146-1152.
77. Jacobs RL, House JD, Brosnan ME, Brosnan JT. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998; 47: 1967-1970.
78. Fiorucci S, Antonelli E, Distrutti E, Rizzo G, Mencarelli A, Orlandi S, et al. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs. Gastroenterology 2005; 129: 1210-1224.
79. Schicho R, Krueger D, Zeller F, Von Weyhern CW, Frieling T, Kimura H, et al. Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. Gastroenterology 2006; 131: 1542-1552.
80. Distrutti E, Sediari L, Mencarelli A, Renga B, Orlandi S, Antonelli E, et al. Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. J Pharmacol Exp Ther 2006; 316: 325-335.
81. 2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis. Hepatology 2005; 42: 539-548.
82. Wallace JL. Hydrogen sulfide-releasing anti-inflammatory drugs. Trends Pharmacol Sci 2007; 28: 501-505.
83. Chuah SC, Moore PK, Zhu YZ. S-allylcysteine mediates cardioprotection in an acute myocardial infarction rat model via a hydrogen sulfide-mediated pathway. Am J Physiol Heart Circ Physiol 2007; 293: H2693-H2701.
84. Benavides GA, Squadrito GL, Mills RW, Patel HD, Isbell TS, Patel RP, et al. Hydrogen sulfide mediates the vasoactivity of garlic. Proc Natl Acad Sci U S A 2007; 104: 17977-17982.
85. Schotborgh CE, Wilde AA. Sulfonylurea derivatives in cardiovascular research and in cardiovascular patients. Cardiovasc Res 1997; 34: 73-80.